Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The company’s stock ran higher after the company buoyed investors’ hopes that its technology will boost a lineup of new popular drugs.
Dirk Van de Put said the company has received no pressure from shareholders to stop doing business with Russia.
The companies continue to lose massive amounts of money as consumers are turning to cheaper hybrids and traditional gas-powered vehicles.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The massive growth by both companies is crowding out other suppliers hoping to rely on cargo delivery planes.
The company’s online sales topped 16% of total sales in its most recent quarter, its highest level yet.
Tesla and other self-driving car firms face both regulatory battles and public perception hurdles.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Demand has been slowing domestically, so Chinese companies are looking abroad to keep sales growing.
The company’s Cruise now has double the road for autonomous driving, but many consumers continue to have safety concerns.
The investigation is targeting so-called middlemen that broker deals between hospitals and pharmaceutical companies.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.